Bristol-Myers Squibb is buying Celgene for $ 74 billion

    Bristol-Myers Squibb is buying Celgene for $ 74 billion

Bristol-Myers Squibb and Celgene can make the biggest deal of the coming year. BMS wants to buy Celgene for $ 74 billion. Official releases say that one share will cost

0 comment Read Full Article

News: US stock market is falling, Apple’s shares have slipped, US is looking for workers

    News: US stock market is falling, Apple’s shares have slipped, US is looking for workers

The US stocks began their rapid decline after the forecasts regarding Apple, concerns about a slowdown in China’s economy and the paralyzing of the US government. The stock price of

0 comment Read Full Article

The Israeli company Teva Pharmaceutical showed a loss of $ 6 billion

    The Israeli company Teva Pharmaceutical showed a loss of $ 6 billion

Investors are worried. One of the largest generics concerns in the world, the Israeli Teva Pharmaceutical, has shown a huge loss on the results of quarterly activity. The amount of

0 comment Read Full Article